Insights About Striatal Circuit Function and Schizophrenia From a Mouse Model of Dopamine D2 Receptor Upregulation

Biological Psychiatry

Volumn 81, Issue 1, 2017, Pages 21-30

  Simpson, Eleanor H ^a,b   Kellendonk, Christoph ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

D2 receptor; Dopamine; Mouse model, Negative symptoms; Schizophrenia; Striatal circuit function

Indexed keywords

BIOLOGICAL MARKER; DOPAMINE; DOPAMINE 2 RECEPTOR;

ANIMAL MODEL; BRAIN CORTEX; COGNITIVE DEFECT; DECISION MAKING; DORSAL STRIATUM; EXECUTIVE FUNCTION; GLOBUS PALLIDUS; HUMAN; LEARNING; MOUSE; MOUSE MODEL; NEGATIVE SYNDROME; NONHUMAN; POSITIVE SYNDROME; PRIORITY JOURNAL; PROBLEM SOLVING; RECEPTOR UPREGULATION; REVIEW; REWARD; SCHIZOPHRENIA; SPATIAL MEMORY; SUBSTANTIA NIGRA; TIME PERCEPTION; TRANSGENIC MOUSE; VENTRAL STRIATUM; WORKING MEMORY; ANIMAL; BRAIN; CORPUS STRIATUM; DISEASE MODEL; METABOLISM; PATHOPHYSIOLOGY; PSYCHOLOGY; UPREGULATION;

ANIMALS; BRAIN; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, TRANSGENIC; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; UP-REGULATION;

EID: 84992110499     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2016.07.004     Document Type: Review

References (109)

1. 1 Baumeister, A.A., Francis, J.L., Historical development of the dopamine hypothesis of schizophrenia. J Hist Neurosci 11 (2002), 265–277.
2. 2 Seeman, P., Lee, T., Chau-Wong, M., Wong, K., Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261 (1976), 717–719.
3. 3 Creese, I., Burt, D.R., Snyder, S.H., Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192 (1976), 481–483.
4. 4 Howes, O.D., Kambeitz, J., Kim, E., Stahl, D., Slifstein, M., Abi-Dargham, A., et al. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch Gen Psychiatry 69 (2012), 776–786.
5. 5 Howes, O.D., Montgomery, A.J., Asselin, M.C., Murray, R.M., Valli, I., Tabraham, P., et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry 66 (2009), 13–20.
6. 6 Egerton, A., Chaddock, C.A., Winton-Brown, T.T., Bloomfield, M.A., Bhattacharyya, S., Allen, P., et al. Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: Findings in a second cohort. Biol Psychiatry 74 (2013), 106–112.
7. 7 Kegeles, L.S., Abi-Dargham, A., Frankle, W.G., Gil, R., Cooper, T.B., Slifstein, M., et al. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Arch Gen Psychiatry 67 (2010), 231–239.
8. 8 Haber, S.N., Kim, K.S., Mailly, P., Calzavara, R., Reward-related cortical inputs define a large striatal region in primates that interface with associative cortical connections, providing a substrate for incentive-based learning. J Neurosci 26 (2006), 8368–8376.
9. 9 Laruelle, M., Imaging dopamine transmission in schizophrenia. A review and meta-analysis. Q J Nucl Med 42 (1998), 211–221.
10. 10 Abi-Dargham, A., Rodenhiser, J., Printz, D., Zea-Ponce, Y., Gil, R., Kegeles, L.S., et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci U S A 97 (2000), 8104–8109.
11. 11 Abi-Dargham, A., van de Giessen, E., Slifstein, M., Kegeles, L.S., Laruelle, M., Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjects. Biol Psychiatry 65 (2009), 1091–1093.
12. 12 Weinberger, D.R., Berman, K.F., Zec, R.F., Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry 43 (1986), 114–124.
13. 13 Berman, K.F., Zec, R.F., Weinberger, D.R., Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort. Arch Gen Psychiatry 43 (1986), 126–135.
14. 14 Weinberger, D.R., Berman, K.F., Illowsky, B.P., Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. Arch Gen Psychiatry 45 (1988), 609–615.
15. 15 Slifstein, M., van de Giessen, E., Van Snellenberg, J., Thompson, J.L., Narendran, R., Gil, R., et al. Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: A positron emission tomographic functional magnetic resonance imaging study. JAMA Psychiatry 72 (2015), 316–324.
16. 16 Ranganath, A., Jacob, S.N., Doping the mind: Dopaminergic modulation of prefrontal cortical cognition. Neuroscientist 22 (2016), 593–603.
17. 17 Suzuki, T., Remington, G., Mulsant, B.H., Rajji, T.K., Uchida, H., Graff-Guerrero, A., et al. Treatment resistant schizophrenia and response to antipsychotics: A review. Schizophr Res 133 (2011), 54–62.
18. 18 Kellendonk, C., Simpson, E.H., Polan, H.J., Malleret, G., Vronskaya, S., Winiger, V., et al. Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49 (2006), 603–615.
19. 19 Morozov, A., Kellendonk, C., Simpson, E., Tronche, F., Using conditional mutagenesis to study the brain. Biol Psychiatry 54 (2003), 1125–1133.
20. 20 Drew, M.R., Simpson, E.H., Kellendonk, C., Herzberg, W.G., Lipatova, O., Fairhurst, S., et al. Transient overexpression of striatal D2 receptors impairs operant motivation and interval timing. J Neurosci 27 (2007), 7731–7739.
21. 21 Cazorla, M., Shegda, M., Ramesh, B., Harrison, N.L., Kellendonk, C., Striatal D2 receptors regulate dendritic morphology of medium spiny neurons via Kir2 channels. J Neurosci 32 (2012), 2398–2409.
22. 22 Green, M.F., What are the functional consequences of neurocognitive deficits in schizophrenia?. Am J Psychiatry 153 (1996), 321–330.
23. 23 Green, M.F., Kern, R.S., Braff, D.L., Mintz, J., Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the “right stuff”?. Schizophr Bull 26 (2000), 119–136.
24. 24 Fervaha, G., Foussias, G., Agid, O., Remington, G., Amotivation and functional outcomes in early schizophrenia. Psychiatry Res 210 (2013), 665–668.
25. 25 Luck, S.J., Gold, J.M., The construct of attention in schizophrenia. Biol Psychiatry 64 (2008), 34–39.
26. 26 Barch, D.M., Smith, E., The cognitive neuroscience of working memory: relevance to CNTRICS and schizophrenia. Biol Psychiatry 64 (2008), 11–17.
27. 27 Kerns, J.G., Nuechterlein, K.H., Braver, T.S., Barch, D.M., Executive functioning component mechanisms and schizophrenia. Biol Psychiatry 64 (2008), 26–33.
28. 28 Kim, J., Glahn, D.C., Nuechterlein, K.H., Cannon, T.D., Maintenance and manipulation of information in schizophrenia: Further evidence for impairment in the central executive component of working memory. Schizophr Res 68 (2004), 173–187.
29. 29 Horan, W.P., Braff, D.L., Nuechterlein, K.H., Sugar, C.A., Cadenhead, K.S., Calkins, M.E., et al. Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: Findings from the Consortium on the Genetics of Schizophrenia. Schizophr Res 103 (2008), 218–228.
30. 30 Gold, J.M., Hahn, B., Zhang, W.W., Robinson, B.M., Kappenman, E.S., Beck, V.M., et al. Reduced capacity but spared precision and maintenance of working memory representations in schizophrenia. Arch Gen Psychiatry 67 (2010), 570–577.
31. 31 Bach, M.E., Simpson, E.H., Kahn, L., Marshall, J.J., Kandel, E.R., Kellendonk, C., Transient and selective overexpression of D2 receptors in the striatum causes persistent deficits in conditional associative learning. Proc Natl Acad Sci U S A 105 (2008), 16027–16032.
32. 32 Braff, D., Stone, C., Callaway, E., Geyer, M., Glick, I., Bali, L., Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15 (1978), 339–343.
33. 33 Kohl, S., Heekeren, K., Klosterkötter, J., Kuhn, J., Prepulse inhibition in psychiatric disorders—Apart from schizophrenia. J Psychiatr Res 47 (2013), 445–452.
34. 34 Wynn, J.K., Green, M.F., Sprock, J., Light, G.A., Widmark, C., Reist, C., et al. Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: A double-blind, randomized controlled trial. Schizophr Res 95 (2007), 134–142.
35. 35 Kellendonk, C., Simpson, E.H., Kandel, E.R., Modeling cognitive endophenotypes of schizophrenia in mice. Trends Neurosci 32 (2009), 347–358.
36. 36 Avlar, B., Kahn, J.B., Jensen, G., Kandel, E.R., Simpson, E.H., Balsam, P.D., Improving temporal cognition by enhancing motivation. Behav Neurosci 129 (2015), 576–588.
37. 37 Miyamoto, S., Miyake, N., Jarskog, L.F., Fleischhacker, W.W., Lieberman, J.A., Pharmacological treatment of schizophrenia: A critical review of the pharmacology and clinical effects of current and future therapeutic agents. Mol Psychiatry 17 (2012), 1206–1227.
38. 38 Ward, R.D., Simpson, E.H., Richards, V.L., Deo, G., Taylor, K., Glendinning, J.I., et al. Dissociation of hedonic reaction to reward and incentive motivation in an animal model of the negative symptoms of schizophrenia. Neuropsychopharmacology 37 (2012), 1699–1707.
39. 39 Simpson, E.H., Kellendonk, C., Ward, R.D., Richards, V., Lipatova, O., Fairhurst, S., et al. Pharmacologic rescue of motivational deficit in an animal model of the negative symptoms of schizophrenia. Biol Psychiatry 69 (2011), 928–935.
40. 40 Simpson, E.H., Balsam, P.D., The behavioral neuroscience of motivation: An overview of concepts, measures, and translational applications. Curr Top Behav Neurosci 27 (2015), 1–12.
41. 41 Reddy, L.F., Horan, W.P., Green, M.F., Motivational deficits and negative symptoms in schizophrenia: Concepts and assessments. Curr Top Behav Neurosci 27 (2015), 357–373.
42. 42 Gard, D.E., Kring, A.M., Gard, M.G., Horan, W.P., Green, M.F., Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure. Schizophr Res 93 (2007), 253–260.
43. 43 Gold, J.M., Strauss, G.P., Waltz, J.A., Robinson, B.M., Brown, J.K., Frank, M.J., Negative symptoms of schizophrenia are associated with abnormal effort-cost computations. Biol Psychiatry 74 (2013), 130–136.
44. 44 Gold, J.M., Waltz, J.A., Frank, M.J., Effort cost computation in schizophrenia: A commentary on the recent literature. Biol Psychiatry 87 (2015), 747–753.
45. 45 Barch, D.M., Treadway, M.T., Schoen, N., Effort, anhedonia, and function in schizophrenia: Reduced effort allocation predicts amotivation and functional impairment. J Abnorm Psychol 123 (2014), 387–397.
46. 46 Treadway, M.T., Peterman, J.S., Zald, D.H., Park, S., Impaired effort allocation in patients with schizophrenia. Schizophr Res 161 (2015), 382–385.
47. 47 Young, J.W., Markou, A., Translational rodent paradigms to investigate neuromechanisms underlying behaviors relevant to amotivation and altered reward processing in schizophrenia. Schizophr Bull 41 (2015), 1024–1034.
48. 48 Simpson, E.H., Waltz, J.A., Kellendonk, C., Balsam, P.D., Schizophrenia in translation: dissecting motivation in schizophrenia and rodents. Schizophr Bull 38 (2012), 1111–1117.
49. 49 Ward, R.D., Simpson, E.H., Kandel, E.R., Balsam, P.D., Modeling motivational deficits in mouse models of schizophrenia: behavior analysis as a guide for neuroscience. Behav Processes 87 (2011), 149–156.
50. 50 Bailey, M.R., Williamson, C., Mezias, C., Winiger, V., Silver, R., Balsam, P.D., et al. The effects of pharmacological modulation of the serotonin 2C receptor on goal-directed behavior in mice. Psychopharmacology (Berl) 233 (2015), 615–624.
51. 51 Winstanley, C.A., Theobald, D.E., Dalley, J.W., Glennon, J.C., Robbins, T.W., 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: Interactions with global 5-HT depletion. Psychopharmacology (Berl) 176 (2004), 376–385.
52. 52 Fletcher, P.J., Tampakeras, M., Sinyard, J., Higgins, G.A., Opposing effects of 5-HT(2A) and 5-HT(2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test. Psychopharmacology (Berl) 195 (2007), 223–234.
53. 53 Strauss, G.P., Waltz, J.A., Gold, J.M., A review of reward processing and motivational impairment in schizophrenia. Schizophr Bull 40:suppl 2 (2014), S107–S116.
54. 54 Fervaha, G., Zakzanis, K.K., Foussias, G., Graff-Guerrero, A., Agid, O., Remington, G., Motivational deficits and cognitive test performance in schizophrenia. JAMA Psychiatry 71 (2014), 1058–1065.
55. 55 Green, M.F., Hellemann, G., Horan, W.P., Lee, J., Wynn, J.K., From perception to functional outcome in schizophrenia: Modeling the role of ability and motivation. Arch Gen Psychiatry 69 (2012), 1216–1224.
56. 56 Ward, R.D., Winiger, V., Higa, K.K., Kahn, J.B., Kandel, E.R., Balsam, P.D., et al. The impact of motivation on cognitive performance in an animal model of the negative and cognitive symptoms of schizophrenia. Behav Neurosci 129 (2015), 292–299.
57. 57 Saperstein, A.M., Medalia, A., The role of motivation in cognitive remediation for people with schizophrenia. Curr Top Behav Neurosci 27 (2016), 533–546.
58. 58 Tarbox, S.I., Pogue-Geile, M.F., Development of social functioning in preschizophrenia children and adolescents: a systematic review. Psychol Bull 134 (2008), 561–583.
59. 59 Kabitzke, P.A., Simpson, E.H., Kandel, E.R., Balsam, P.D., Social behavior in a genetic model of dopamine dysfunction at different neurodevelopmental time points. Genes Brain Behav 14 (2015), 503–515.
60. 60 Bertolino, A., Taurisano, P., Pisciotta, N.M., Blasi, G., Fazio, L., Romano, R., et al. Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance. PLoS ONE, 5, 2010, e9348.
61. 61 Landau, S.M., Lal, R., O'Neil, J.P., Baker, S., Jagust, W.J., Striatal dopamine and working memory. Cereb Cortex 19 (2009), 445–454.
62. 62 Braskie, M.N., Landau, S.M., Wilcox, C.E., Taylor, S.D., O'Neil, J.P., Baker, S.L., et al. Correlations of striatal dopamine synthesis with default network deactivations during working memory in younger adults. Hum Brain Mapp 32 (2011), 947–961.
63. 63 Arnsten, A.F., Wang, M.J., Paspalas, C.D., Neuromodulation of thought: flexibilities and vulnerabilities in prefrontal cortical network synapses. Neuron 76 (2012), 223–239.
64. 64 Zahrt, J., Taylor, J.R., Mathew, R.G., Arnsten, A.F., Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 17 (1997), 8528–8535.
65. 65 Krabbe, S., Duda, J., Schiemann, J., Poetschke, C., Schneider, G., Kandel, E.R., et al. Increased dopamine D2 receptor activity in the striatum alters the firing pattern of dopamine neurons in the ventral tegmental area. Proc Natl Acad Sci U S A 112 (2015), E1498–E1506.
66. 66 Lieberman, J.A., Dixon, L.B., Goldman, H.H., Early detection and intervention in schizophrenia: A new therapeutic model. JAMA, 310, 2013, 689–690.
67. 67 Zweifel, L.S., Parker, J.G., Lobb, C.J., Rainwater, A., Wall, V.Z., Fadok, J.P., et al. Disruption of NMDAR-dependent burst firing by dopamine neurons provides selective assessment of phasic dopamine-dependent behavior. Proc Natl Acad Sci U S A 106 (2009), 7281–7288.
68. 68 Javitt, D.C., Treatment of negative and cognitive symptoms. Curr Psychiatry Rep 1 (1999), 25–30.
69. 69 Umbricht, D., Alberati, D., Martin-Facklam, M., Borroni, E., Youssef, E.A., Ostland, M., et al. Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: A randomized, double-blind, proof-of-concept study. JAMA Psychiatry 71 (2014), 637–646.
70. 70 Meyer-Lindenberg, A., Miletich, R.S., Kohn, P.D., Esposito, G., Carson, R.E., Quarantelli, M., et al. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci 5 (2002), 267–271.
71. 71 Fusar-Poli, P., Howes, O.D., Allen, P., Broome, M., Valli, I., Asselin, M.C., et al. Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis. Mol Psychiatry 16 (2011), 67–75.
72. 72 Pycock, C.J., Carter, C.J., Kerwin, R.W., Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the rat. J Neurochem 34 (1980), 91–99.
73. 73 Roberts, A.C., De Salvia, M.A., Wilkinson, L.S., Collins, P., Muir, J.L., Everitt, B.J., et al. 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test: Possible interactions with subcortical dopamine. J Neurosci 14 (1994), 2531–2544.
74. 74 Kim, I.H., Rossi, M.A., Aryal, D.K., Racz, B., Kim, N., Uezu, A., et al. Spine pruning drives antipsychotic-sensitive locomotion via circuit control of striatal dopamine. Nat Neurosci 18 (2015), 883–891.
75. 75 Li, Y.C., Kellendonk, C., Simpson, E.H., Kandel, E.R., Gao, W.J., D2 receptor overexpression in the striatum leads to a deficit in inhibitory transmission and dopamine sensitivity in mouse prefrontal cortex. Proc Natl Acad Sci U S A 108 (2011), 12107–12112.
76. 76 Ward, R.D., Kellendonk, C., Simpson, E.H., Lipatova, O., Drew, M.R., Fairhurst, S., et al. Impaired timing precision produced by striatal D2 receptor overexpression is mediated by cognitive and motivational deficits. Behav Neurosci 123 (2009), 720–730.
77. 77 Mingote, S., Weber, S.M., Ishiwari, K., Correa, M., Salamone, J.D., Ratio and time requirements on operant schedules: Effort-related effects of nucleus accumbens dopamine depletions. Eur J Neurosci 21 (2005), 1749–1757.
78. 78 Nunes, E.J., Randall, P.A., Podurgiel, S., Correa, M., Salamone, J.D., Nucleus accumbens neurotransmission and effort-related choice behavior in food motivation: Effects of drugs acting on dopamine, adenosine, and muscarinic acetylcholine receptors. Neurosci Biobehav Rev 37 (2013), 2015–2025.
79. 79 Cagniard, B., Beeler, J.A., Britt, J.P., McGehee, D.S., Marinelli, M., Zhuang, X., Dopamine scales performance in the absence of new learning. Neuron 51 (2006), 541–547.
80. 80 Gerfen, C.R., Surmeier, D.J., Modulation of striatal projection systems by dopamine. Annu Rev Neurosci 34 (2011), 441–466.
81. 81 Albin, R.L., Young, A.B., Penney, J.B., The functional anatomy of basal ganglia disorders. Trends Neurosci 12 (1989), 366–375.
82. 82 Kawaguchi, Y., Wilson, C.J., Emson, P.C., Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. J Neurosci 10 (1990), 3421–3438.
83. 83 Lévesque, M., Parent, A., The striatofugal fiber system in primates: a reevaluation of its organization based on single-axon tracing studies. Proc Natl Acad Sci U S A 102 (2005), 11888–11893.
84. 84 Fujiyama, F., Sohn, J., Nakano, T., Furuta, T., Nakamura, K.C., Matsuda, W., et al. Exclusive and common targets of neostriatofugal projections of rat striosome neurons: A single neuron-tracing study using a viral vector. Eur J Neurosci 33 (2011), 668–677.
85. 85 Wu, Y., Richard, S., Parent, A., The organization of the striatal output system: a single-cell juxtacellular labeling study in the rat. Neurosci Res 38 (2000), 49–62.
86. 86 Cazorla, M., de Carvalho, F.D., Chohan, M.O., Shegda, M., Chuhma, N., Rayport, S., et al. Dopamine D2 receptors regulate the anatomical and functional balance of basal ganglia circuitry. Neuron 81 (2014), 153–164.
87. 87 Kupchik, Y.M., Brown, R.M., Heinsbroek, J.A., Lobo, M.K., Schwartz, D.J., Kalivas, P.W., Coding the direct/indirect pathways by D1 and D2 receptors is not valid for accumbens projections. Nat Neurosci 18 (2015), 1230–1232.
88. 88 Kravitz, A.V., Tye, L.D., Kreitzer, A.C., Distinct roles for direct and indirect pathway striatal neurons in reinforcement. Nat Neurosci 15 (2012), 816–818.
89. 89 Sherwood, M., Thornton, A.E., Honer, W.G., A meta-analysis of profile and time-course of symptom change in acute schizophrenia treated with atypical antipsychotics. Int J Neuropsychopharmacol 9 (2006), 357–366.
90. 90 Mathur, B.N., Lovinger, D.M., Endocannabinoid-dopamine interactions in striatal synaptic plasticity. Front Pharmacol, 3, 2012, 66.
91. 91 Kemali, D., Maj, M., Galderisi, S., Monteleone, P., Mucci, A., Conditional associative learning in drug-free schizophrenic patients. Neuropsychobiology 17 (1987), 30–34.
92. 92 Gold, J.M., Bish, J.A., Iannone, V.N., Hobart, M.P., Queern, C.A., Buchanan, R.W., Effects of contextual processing on visual conditional associative learning in schizophrenia. Biol Psychiatry 48 (2000), 406–414.
93. 93 Ford, J.M., Gray, M., Whitfield, S.L., Turken, A.U., Glover, G., Faustman, W.O., et al. Acquiring and inhibiting prepotent responses in schizophrenia: Event-related brain potentials and functional magnetic resonance imaging. Arch Gen Psychiatry 61 (2004), 119–129.
94. 94 Leeson, V.C., Robbins, T.W., Matheson, E., Hutton, S.B., Ron, M.A., Barnes, T.R., et al. Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: Stability over six years and specific associations with medication type and disorganization syndrome. Biol Psychiatry 66 (2009), 586–593.
95. 95 Carroll, C.A., Boggs, J., O'Donnell, B.F., Shekhar, A., Hetrick, W.P., Temporal processing dysfunction in schizophrenia. Brain Cogn 67 (2008), 150–161.
96. 96 Carroll, C.A., O'Donnell, B.F., Shekhar, A., Hetrick, W.P., Timing dysfunctions in schizophrenia as measured by a repetitive finger tapping task. Brain Cogn 71 (2009), 345–353.
97. 97 Park, S., Holzman, P.S., Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry 49 (1992), 975–982.
98. 98 Holmén, A., Juuhl-Langseth, M., Thormodsen, R., Sundet, K., Melle, I., Rund, B.R., Executive function tests in early-onset psychosis: Which one to choose?. Scand J Psychol 53 (2012), 200–205.
99. 99 Ben Abdallah, N.M., Fuss, J., Trusel, M., Galsworthy, M.J., Bobsin, K., Colacicco, G., et al. The puzzle box as a simple and efficient behavioral test for exploring impairments of general cognition and executive functions in mouse models of schizophrenia. Exp Neurol 227 (2011), 42–52.
100. 100 Berlin, I., Givry-Steiner, L., Lecrubier, Y., Puech, A.J., Measures of anhedonia and hedonic responses to sucrose in depressive and schizophrenic patients in comparison with healthy subjects. Eur Psychiatry 13 (1998), 303–309.
101. 101 Glendinning, J.I., Gresack, J., Spector, A.C., A high-throughput screening procedure for identifying mice with aberrant taste and oromotor function. Chem Senses 27 (2002), 461–474.
102. 102 Berridge, K.C., Measuring hedonic impact in animals and infants: microstructure of affective taste reactivity patterns. Neurosci Biobehav Rev 24 (2000), 173–198.
103. 103 Wolf, D.H., Satterthwaite, T.D., Kantrowitz, J.J., Katchmar, N., Vandekar, L., Elliott, M.A., et al. Amotivation in schizophrenia: Integrated assessment with behavioral, clinical, and imaging measures. Schizophr Bull 40 (2014), 1328–1337.
104. 104 Strauss, G.P., Whearty, K.M., Morra, L.F., Sullivan, S.K., Ossenfort, K.L., Frost, K.H., Avolition in schizophrenia is associated with reduced willingness to expend effort for reward on a Progressive Ratio task. Schizophr Res 170 (2016), 198–204.
105. 105 Hodos, W., Progressive ratio as a measure of reward strength. Science 134 (1961), 943–944.
106. 106 McCarthy, J.M., Treadway, M.T., Bennett, M.E., Blanchard, J.J., Inefficient effort allocation and negative symptoms in individuals with schizophrenia. Schizophr Res 170 (2016), 278–284.
107. 107 Salamone, J.D., Steinpreis, R.E., McCullough, L.D., Smith, P., Grebel, D., Mahan, K., Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure. Psychopharmacology (Berl) 104 (1991), 515–521.
108. 108 Heerey, E.A., Bell-Warren, K.R., Gold, J.M., Decision-making impairments in the context of intact reward sensitivity in schizophrenia. Biol Psychiatry 64 (2008), 62–69.
109. 109 Herrnstein, R.J., Relative and absolute strength of response as a function of frequency of reinforcement. J Exp Anal Behav 4 (1961), 267–272.